Comments

Atossa Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Atossa Therapeutics (ATOS) operate in?

Atossa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ATOSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.8795

0.002100.24%

At close: -

$0.8795

0.000.00%

After Hours: 4:34 PM EDT

Atossa Therapeutics (ATOS) Forecast

News Earnings Atossa Therapeutics (ATOS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Atossa Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ATOS | Benzinga

Explore Atossa Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ATOS.

Open	$0.90
Close	$0.88
Volume / Avg.	16.35M / 722.37K
Day Range	$0.87 - $0.91
52 Wk Range	0.55 - 1.66
Market Cap	$113.61M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	56
Short Interest	5.74%
Days to Cover	11.66

Recent News

This Excelerate Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

Partner Content

This Biotech Works On All Phases Of Breast Cancer, From Prevention To Post Surgery

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Mar

Apr

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.90
Close	$0.88
Volume / Avg.	16.35M / 722.37K
Day Range	$0.87 - $0.91
52 Wk Range	0.55 - 1.66
Market Cap	$113.61M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	56
Short Interest	5.74%
Days to Cover	11.66

About Atossa Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicin...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Atossa Therapeutics (ATOS) stock?

You can purchase shares of Atossa Therapeutics (NASDAQ:ATOS) through any online brokerage.

View our list of the best stock brokerages

Who are Atossa Therapeutics (ATOS) competitors?

Other companies in Atossa Therapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), Korro Bio (NASDAQ:KRRO), Immuneering (NASDAQ:IMRX), Genelux (NASDAQ:GNLX) and Greenwich LifeSciences (NASDAQ:GLSI).

What is the forecast, or price target, for Atossa Therapeutics (ATOS) stock?

Atossa Therapeutics has a consensus price target of $6.17.

What is the current price for Atossa Therapeutics (ATOS)?

The stock price for Atossa Therapeutics (NASDAQ: ATOS) is $0.8795 last updated June 27, 2025 at 4:34 PM EDT.

Does Atossa Therapeutics (ATOS) pay a dividend?

There are no upcoming dividends for Atossa Therapeutics.

When is Atossa Therapeutics (NASDAQ:ATOS) reporting earnings?

Atossa Therapeutics’s Q2 earnings are confirmed for Monday, August 11, 2025.

Is Atossa Therapeutics (ATOS) going to split?

There is no upcoming split for Atossa Therapeutics.

What sector and industry does Atossa Therapeutics (ATOS) operate in?

Atossa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.